Relative sensitivity of thyroid fine-needle aspiration by tumor type and size

Diagnostic Cytopathology

Volumn 41, Issue 10, 2013, Pages 871-875

  Jo, Vickie Y ^a   Renshaw, Andrew A ^b   Krane, Jeffrey F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

fine needle aspiration; sensitivity; size; thyroid

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID TUMOR; TUMOR VOLUME;

FINE-NEEDLE ASPIRATION; SENSITIVITY; SIZE; THYROID;

BIOPSY, FINE-NEEDLE; CARCINOMA; HUMANS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS;

EID: 84885019216     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22976     Document Type: Article

References (17)

1. Ali SZ, Cibas ES,. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes. New York, NY: Springer; 2010.
2. Cibas ES, Ali SZ,. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2009; 132: 658-665.
3. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: A summation. CytoJournal 2008; 5: 6.
4. Theoharis C, Schofield K, Hammers L, Udelsman R, Chhieng D,. The Bethesda thyroid fine-needle aspiration classification system: Year 1 at an academic institution. Thyroid 2009; 19: 1215-1223.
5. Marchevsky AM, Walts AE, Bose S, Gupta R,. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol 2009; 38: 252-259.
6. Jo VY, Stelow EB, Dustin SM, Hanley KZ,. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2010; 134: 450-456.
7. Renshaw AA,. Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 2010; 118: 186-189.
8. Wu HH-J, Rose C, Elsheikh TM,. The Bethesda System for Reporting Thyroid Cytopathology: An Experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol 2012; 40: 399-403.
9. Kurian EM, Dawlett M, Wang J, Gong Y, Guo M,. The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda Reporting Guidelines. Diagn Cytopathol 2012; 40 (Suppl): E69-E73.
10. Renshaw AA,. Sensitivity of fine-needle aspiration for papillary carcinoma of the thyroid correlates with tumor size. Diagn Cytopathol 2010; 39: 471-474.
11. VanderLaan PA, Marqusee E, Krane JF,. Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol 2012; 120: 245-253.
12. Dustin SM, Jo VY, Stelow EB, Hanley KZ,. High sensitivity and positive predictive value of fine-needle aspiration for uncommon thyroid malignancies. Diagn Cytopathol 2012; 40: 416-421.
13. Bongiovanni M, Bloom L, Krane JF, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma: A multi-institutional analysis of 40 cases. Cancer Cytopathol 2009; 117: 185-194.
14. VanderLaan PA, Marqusee E, Krane JF,. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol 2011; 136: 572-577.
15. Jo VY, VanderLaan PA, Marqusee E, Krane JF,. Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy risk. Acta Cytol 2011; 55: 539-543.
16. Biscotti C, Hollow J, Toddy S, Easley K,. ThinPrep versus conventional smear cytologic preparations in the analysis of thyroid fine-needle aspiration specimens. Am J Clin Pathol 1995; 104: 150-153.
17. Luu MH, Fischer AH, Pisharodi L, Owens CL,. Improved preoperative definitive diagnosis of papillary thyroid carcinoma in FNAs prepared with both ThinPrep and conventional smears compared with FNAs prepared with ThinPrep alone. Cancer Cytopathol 2011; 119: 68-73.